Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients

Clinical trial NCT02172352 · COMPLETED

Trial details

NCT number: NCT02172352
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 1998-07-01
Primary completion: 1999-05-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.